Gland Pharma reported a 22.5% revenue increase to Rs 1695 crore and a 27.7% rise in net profit to Rs 262 crore for Q3, with EBITDA growing 20.8% to Rs 435 crore.
Related Posts
Chile declares emergency as wildfires kill at least 15
- nationalpillarnews
- January 18, 2026
- 0
Security Minister Luis Cordero gave the tolls for the blazes burning for two days now in the Nuble and Biobio regions about 500 kilometers (300 […]
IPO calendar: 5 new issues to hit the market next week, Shadowfax to debut on bourses
- nationalpillarnews
- January 24, 2026
- 0
The primary market anticipates a quiet week with no mainboard public offerings. Investor focus will shift to SME platforms, featuring five IPOs. Shadowfax Technologies is […]
How is China framing its Antarctic ambitions? | Explained
- nationalpillarnews
- January 27, 2026
- 0
What is the proposed Antarctic Activities and Environmental Protection Law?